Task: Answer the multiple choice question.
Question: Which drug exhibits a 2.214% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) Cc1ccccc1N1C(=O)CC(Nc2ccc3c(c2)OCO3)C1=O
(b) COc1ccnc(Oc2ccccc2)c1C(=O)N/C=N/OCc1ccccc1F
(c) CC(=O)/C(=N\Nc1ccc(C)cc1)N1CCOCC1
Answer: a. Cc1ccccc1N1C(=O)CC(Nc2ccc3c(c2)OCO3)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccccc1N1C(=O)CC(Nc2ccc3c(c2)OCO3)C1=O
Cc1ccccc1N1C(=O)CC(Nc2ccc3c(c2)OCO3)C1=O
3-(1,3-benzodioxol-5-ylamino)-1-(2-methylphenyl)pyrrolidine-2,5-dione